10-Q: Xsolla SPAC 1 Q3 2025: IPO Fuels $204M Trust Account

Xsolla SPAC 1 reports a net loss for Q3 2025 but successfully completed its initial public offering and private placement in early 2026, raising over $204 million for its trust account to pursue a business combination.

Summary

• Xsolla SPAC 1 is a blank check company incorporated on September 16, 2025, with the purpose of effecting a business combination.
• For the period from inception (September 16, 2025) through September 30, 2025, the company reported a net loss of $46,662, primarily due to formation, general, and administrative costs.
• As of September 30, 2025, the company had no cash, total assets of $82,400, total liabilities of $104,062, and a working capital deficit of $79,062.
• Subsequent to the reporting period, the company successfully completed its Initial Public Offering (IPO) on January 30, 2026, selling 20,000,000 units at $10.00 per unit, generating $200,000,000.
• An additional 419,385 units were sold on February 2, 2026, through a partial exercise of the underwriters' over-allotment option, raising an extra $4,193,850.
• The Sponsor also purchased 400,000 Private Placement Units for $4,000,000 and an additional 3,146 Private Placement Units for $31,460.
• A total of $204,193,850 from the IPO and private placements was placed into a Trust Account by February 2, 2026, to be used for a future business combination.
• Transaction costs for the IPO and over-allotment exercise amounted to $2,674,141.
• The company's management believes it has sufficient funds to finance working capital needs for one year post-IPO.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development for a SPAC, having successfully completed its initial capital raise and established a substantial trust account, which is a critical first step towards a business combination. The initial financial deficit is typical for a pre-IPO SPAC.

Positives

• Successful completion of the Initial Public Offering on January 30, 2026, raising $200,000,000.
• Partial exercise of the over-allotment option on February 2, 2026, generating an additional $4,193,850.
• Successful private placement of units to the Sponsor, raising $4,031,460.
• A total of $204,193,850 has been placed in the Trust Account, providing substantial capital for a future business combination.
• Management believes the company has sufficient funds to meet working capital needs for one year post-IPO.

Negatives

• Reported a net loss of $46,662 for the period from inception (September 16, 2025) through September 30, 2025.
• Had no cash and a working capital deficit of $79,062 as of September 30, 2025, prior to the IPO.
• Disclosure controls and procedures were not effective as of September 30, 2025, although financial statements were deemed accurate.
• The company is a blank check company and has not yet identified a specific business combination target, nor engaged in substantive discussions.
• The underwriters forfeited the remaining unexercised balance of 2,580,615 over-allotment option Units on March 11, 2026.

Risks

• Various social and political circumstances globally (including wars, conflicts, trade tensions, terrorist acts, catastrophic events, and global health epidemics) may contribute to increased market volatility and economic uncertainties, potentially affecting the company's ability to complete a business combination.
• Specifically, the rising conflict between Russia and Ukraine, and conflicts in the Middle East, and resulting market volatility could adversely affect the company's ability to complete a business combination.
• Sanctions, export controls, tariffs, trade wars, and other governmental actions could have a material adverse effect on the company's ability to complete a business combination and the value of its securities.
• There is no assurance that the company will be able to successfully effect a business combination within the 24-month Combination Period.
• If the company fails to complete a business combination within the Combination Period, public shareholders' rights will be extinguished, and warrants will expire worthless.
• The Sponsor's indemnification obligations for claims against the Trust Account are not reserved for, and the Sponsor's only assets are company securities, meaning the company cannot assure the Sponsor would be able to satisfy those obligations, potentially reducing funds available for redemptions.
• If the estimate of costs for identifying a target business, due diligence, and negotiating a business combination is less than the actual amount, the company may have insufficient funds to operate prior to the initial business combination.

Future Outlook

The company intends to use substantially all of the $204,193,850 held in the Trust Account to complete a business combination within 24 months from the closing of the IPO (January 30, 2026). Management expects to generate non-operating income from interest or dividend income on these investments. The company will continue to incur significant costs in pursuit of its acquisition plans and may need additional financing if initial estimates for identifying and negotiating a business combination are insufficient or if a significant number of public shares are redeemed.

Management Comments

• "We intend to effectuate our Business Combination using cash derived from the proceeds of the Initial Public Offering and the sale of the Private Placement Units, our shares, debt or a combination of cash, shares and debt."
• "We expect to continue to incur significant costs in the pursuit of our acquisition plans."
• "We do not expect to generate any operating revenues until after the completion of our Business Combination."
• "Management has determined that upon the consummation of the Initial Public Offering, the sale of the Private Placement Units, and the sale of additional Units as a result of the partial exercise by the underwriters of their over-allotment option, the Company has sufficient funds to finance the working capital needs of the Company within one year from the date of issuance of the unaudited financial statements."
• "Our Certifying Officers concluded that our disclosure controls and procedures were not effective as of the end of the quarterly period ended September 30, 2025. However, the Certifying Officers completed a review of the accounting for material transactions covering this interim period and determined that the financial statements presented were complete and accurate and in conformity with U.S. generally accepted accounting principles. The Certifying Officers intend to add or adjust procedures going forward in order to meet requirements for adequate internal controls over financial reporting."

Industry Context

StockSavvy.ai notes that Xsolla SPAC 1's filing is typical for a Special Purpose Acquisition Company (SPAC) in its early stages. The successful completion of its IPO and private placement, raising over $204 million for its trust account, positions it to pursue its primary objective of a business combination. The reported net loss and working capital deficit for the initial period are expected for a blank check company prior to its IPO and acquisition target identification. The disclosure regarding ineffective disclosure controls, while addressed by management, highlights a common challenge for newly public entities in establishing robust internal controls.

Comparison to Industry Standards

• The IPO pricing of $10.00 per unit is standard for SPACs, aiming to provide a stable base for public shareholders.
• The 24-month "Combination Period" to complete a business combination aligns with typical SPAC timelines, such as those seen in other recent SPACs like Gores Holdings VIII or Churchill Capital Corp.
• The structure of Founder Shares representing 20.0% of outstanding shares post-IPO is a common practice to incentivize the Sponsor, similar to many SPACs that launched in 2021-2023.
• The exercise price of $11.50 per warrant is also a standard premium over the IPO unit price, consistent with the warrant terms of most SPACs.
• The redemption rights for public shareholders, allowing them to redeem shares for a pro rata portion of the Trust Account, are a fundamental protection mechanism in the SPAC market, comparable to those offered by other SPACs.

Management Changes

Corporate Governance

Legal Proceedings

• Not a party to any material legal proceedings, and no material legal proceedings have been threatened.

Related Party Transactions

• Promissory note from the Sponsor for up to $2,000,000, with $58,492 outstanding as of September 30, 2025. The note was fully repaid by March 16, 2026.
• Sponsor received 9,583,333 Class B ordinary shares (Founder Shares) in exchange for a $25,000 payment of company expense.
• Sponsor surrendered 1,916,666 Founder Shares on January 28, 2026, and 860,205 Founder Shares on March 11, 2026, for no consideration.
• Sponsor purchased 400,000 Private Placement Units for $4,000,000 and an additional 3,146 Private Placement Units for $31,460.
• Sponsor entered into an agreement to transfer 660,006 Founder Shares to independent directors and officers.
• Agreement with the Sponsor, commencing January 28, 2026, to pay a monthly fee of $10,000 for office space, administrative and shared personnel support services.
• Sponsor or affiliates may loan the company funds (Working Capital Loans) to finance transaction costs for a Business Combination, with up to $1,500,000 convertible into units.

Stakeholder Impact

• Shareholders (Public): Have redemption rights for their Public Shares at a pro rata portion of the Trust Account if a business combination is not completed or if they choose to redeem. Their investment is held in a trust account.
• Shareholders (Sponsor/Founder): Hold Founder Shares and Private Placement Units, which are subject to transfer restrictions and forfeiture conditions. They waive redemption rights for their Founder Shares.
• Underwriters: Received cash underwriting discounts and Representative Shares for their services in the IPO.
• Independent Directors and Officers: Received Founder Shares in exchange for their services.
• Creditors: The Sponsor has agreed to be liable for certain claims that reduce the Trust Account below a threshold, though the enforceability and Sponsor's ability to satisfy these are not assured.

Next Steps

• Identify and evaluate target businesses for a business combination.
• Perform business due diligence on prospective target businesses.
• Negotiate and complete a business combination within 24 months from the IPO closing (January 30, 2026).
• Add or adjust procedures to meet requirements for adequate internal controls over financial reporting.
• File a registration statement covering the issuance of Class A ordinary shares issuable upon exercise of warrants within 30 days after the consummation of an initial Business Combination.

Key Dates

Recommendation

As a blank check company (SPAC) that has successfully completed its IPO and secured a substantial trust account, Xsolla SPAC 1 is in its initial phase of seeking a business combination. The current financial results reflect pre-operational status, which is expected. The primary investment decision hinges on the quality of the future business combination target, which is currently unknown. Therefore, a "hold" recommendation is appropriate for seasoned investors, as the company has met its initial capital-raising milestones, but the speculative nature of a SPAC prior to identifying a target warrants caution rather than a strong buy, and there's no immediate reason to sell given the funds in trust.

Keywords

SPAC, Blank Check Company, Initial Public Offering, Business Combination, Xsolla SPAC 1, Trust Account, Warrants, Private Placement, SEC Filing, 10-Q, Financial Report, Corporate Governance, Risk Factors